Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - 9 months ended Sep. 30, 2017 - USD ($)
Common Stock [Member]
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2016 57,617,545      
Beginning balance, value at Dec. 31, 2016 $ 5,762 $ 43,333,176 $ (30,130,789) $ 13,208,149
Shares issued pursuant to conversion of senior convertible promissory notes and accrued interest, shares 7,502,829      
Shares issued pursuant to conversion of senior convertible promissory notes and accrued interest, value $ 750 1,654,250   1,655,000
Stock redemptions, shares 398,053      
Stock redemptions, value $ 40 74,960   75,000
Shares issued to settle restricted stock units, shares 2,000,000      
Shares issued to settle restricted stock units, value $ 200 (200)    
Shares issued pursuant to CanX Acquisition, shares 15,000,000      
Shares issued pursuant to CanX Acquisition, value $ 1,500 (1,500)    
Shares issued pursuant to CanX Royalty Buyout 6,400,000      
Shares issued pursuant to CanX Royalty Buyout $ 640 2,431,360   2,432,000
Shares issued in exchange for professional services, shares 500,000      
Shares issued in exchange for professional services, value $ 50 201,950   202,000
Stock-based compensation   3,072,224   3,072,224
Net loss     (5,366,946) (5,366,946)
Ending balance, shares at Sep. 30, 2017 89,418,427      
Ending balance, value at Sep. 30, 2017 $ 8,942 $ 50,766,220 $ (35,497,735) $ 15,277,427